1/13/26 17:11 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Hollywood Mark | DE | O | EVP,COO | M.d | 0 | 0.00 | 0 | 18 | 15 | 133 | D | | | | | | | | | | | | | | |
1/13/26 17:11 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Hollywood Mark | DE | O | EVP,COO | S.d | -139 | 22.67 | 0 | -6 | -4 | 133 | D | | | | | | | | | | | | | | |
1/12/26 21:00 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 18 | 195 | 27 | D | | | | | | | | | | | | | | |
1/12/26 21:00 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | S.d | -211 | 22.67 | 0 | -9 | -26 | 27 | D | | | | | | | | | | | | | | |
1/12/26 20:32 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | M.d | 0 | 0.00 | 0 | 18 | 57 | 48 | D | | | | | | | | | | | | | | |
1/12/26 20:32 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | S.d | -217 | 22.67 | 0 | -10 | -16 | 48 | D | | | | | | | | | | | | | | |
1/12/26 19:07 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | M.d | 0 | 0.00 | 0 | 64 | 39 | 227 | D | | | | | | | | | | | | | | |
1/12/26 19:07 | 1/12/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | S.d | -690 | 22.67 | 0 | -30 | -12 | 227 | D | | | | | | | | | | | | | | |
1/5/26 20:22 | 1/5/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 20 | | 18 | D | | | | | | | | | | | | | | |
1/5/26 20:22 | 1/5/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | S.d | -264 | 25.10 | 0 | -11 | -36 | 18 | D | | | | | | | | | | | | | | |
1/5/26 20:20 | 1/5/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | M.d | 0 | 0.00 | 0 | 114 | 145 | 193 | D | | | | | | | | | | | | | | |
1/5/26 20:20 | 1/5/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | S.d | -1,364 | 25.10 | 0 | -54 | -22 | 193 | D | | | | | | | | | | | | | | |
1/5/26 20:18 | 1/5/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | M.d | 0 | 0.00 | 0 | 37 | 999% | 40 | D | | | | | | | | | | | | | | |
1/5/26 20:18 | 1/5/26 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | S.d | -505 | 25.10 | 0 | -20 | -33 | 40 | D | | | | | | | | | | | | | | |
12/22/25 17:52 | 12/22/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | M.d | 0 | 0.00 | 0 | 100 | 301 | 133 | D | | | | | | | | | | | | | | |
12/22/25 17:52 | 12/22/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | S.d | -1,284 | 27.02 | 0 | -48 | -26 | 133 | D | | | | | | | | | | | | | | |
5/19/25 18:35 | 5/15/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 636 | 11.47 | 0 | 55 | 0 | 17,884 | I | | | | | | | | | | | | | | |
4/18/25 15:17 | 4/16/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 1,456 | 11.32 | 0 | 129 | 1 | 17,828 | I | | | | | | | | | | | | | | |
4/7/25 18:34 | 4/3/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 3,624 | 11.42 | 0 | 317 | 2 | 17,700 | I | | | | | | | | | | | | | | |
4/2/25 19:02 | 3/31/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 1,497 | 11.75 | 0 | 127 | 1 | 17,383 | I | | | | | | | | | | | | | | |
3/27/25 18:53 | 3/25/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 1,227 | 12.61 | 0 | 97 | 1 | 17,255 | I | | | | | | | | | | | | | | |
3/24/25 17:45 | 3/20/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 1,643 | 12.92 | 0 | 127 | 1 | 17,158 | I | | | | | | | | | | | | | | |
3/19/25 18:32 | 3/17/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 2,867 | 12.55 | 0 | 228 | 1 | 17,031 | I | | | | | | | | | | | | | | |
3/13/25 19:35 | 3/11/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 13,121 | 12.13 | 0 | 1,082 | 7 | 16,802 | I | | | | | | | | | | | | | | |
1/21/25 17:34 | 1/16/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 1,964 | 13.88 | 0 | 141 | 1 | 15,720 | I | | | | | | | | | | | | | | |
1/15/25 18:12 | 1/13/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 2,279 | 13.59 | 0 | 168 | 1 | 15,579 | I | | | | | | | | | | | | | | |
1/10/25 18:27 | 1/8/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 2,975 | 13.21 | 0 | 225 | 1 | 15,411 | I | | | | | | | | | | | | | | |
1/6/25 20:35 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | M.d | 0 | 0.00 | 0 | 37 | | 23 | D | | | | | | | | | | | | | | |
1/6/25 20:35 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | S.d | -316 | 14.92 | 0 | -21 | -48 | 23 | D | | | | | | | | | | | | | | |
1/6/25 20:34 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | M.d | 0 | 0.00 | 0 | 114 | | 81 | D | | | | | | | | | | | | | | |
1/6/25 20:34 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | S.d | -855 | 14.92 | 0 | -57 | -41 | 81 | D | | | | | | | | | | | | | | |
1/6/25 20:19 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | M.d | 0 | 0.00 | 0 | 20 | | 9 | D | | | | | | | | | | | | | | |
1/6/25 20:19 | 1/6/25 | ZYME | Health | Drug | Pharmaceutical Preparations | Smith Jeffrey T L | DE | O | EVP,Chie | S.d | -166 | 14.92 | 0 | -11 | -56 | 9 | D | | | | | | | | | | | | | | |
1/2/25 17:51 | 12/30/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 5,321 | 14.64 | 0 | 363 | 2 | 15,186 | I | | | | | | | | | | | | | | |
12/27/24 18:41 | 12/24/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.m | 1,882 | 14.44 | 0 | 130 | 1 | 14,823 | I | | | | | | | | | | | | | | |
12/26/24 12:46 | 12/19/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | DT | | P.am | 17,544 | 13.98 | 0 | 1,255 | 9 | 14,692 | I | | | | | | | | | | | | | | |
1/8/24 18:23 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | M.d | 0 | 0.00 | 0 | 48 | | 24 | D | | | | | | | | | | | | | | |
1/8/24 18:23 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Galbraith Kenneth | DE | DO | Chair,CE | S.dm | -258 | 10.79 | 0 | -24 | -50 | 24 | D | | | | | | | | | | | | | | |
1/8/24 18:14 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Astle Christopher | DE | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 11 | | 7 | D | | | | | | | | | | | | | | |
1/8/24 18:14 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Astle Christopher | DE | O | SVP,CFO | S.dm | -65 | 10.79 | 0 | -6 | -48 | 7 | D | | | | | | | | | | | | | | |
1/8/24 18:01 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | M.d | 0 | 0.00 | 0 | 17 | | 7 | D | | | | | | | | | | | | | | |
1/8/24 18:01 | 1/5/24 | ZYME | Health | Drug | Pharmaceutical Preparations | Moore Paul Andrew | DE | O | Chief Sc | S.dm | -106 | 10.79 | 0 | -10 | -57 | 7 | D | | | | | | | | | | | | | | |
12/11/23 20:00 | 12/11/23 | ZYME | Health | Drug | Pharmaceutical Preparations | Astle Christopher | DE | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 2 | 347 | 2 | D | | | | | | | | | | | | | | |
12/11/23 20:00 | 12/11/23 | ZYME | Health | Drug | Pharmaceutical Preparations | Astle Christopher | DE | O | SVP,CFO | S.d | -8 | 9.13 | 0 | -1 | -31 | 2 | D | | | | | | | | | | | | | | |
6/21/23 16:04 | 6/16/23 | ZYME | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | | P | 27,202 | 8.12 | 0 | 3,350 | 33 | 13,437 | I | | | | | | | | | | | | | | |